Toripalimab Plus FLOT in Locally Advanced Gastric Cancer

NCT04891016 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chemotherapy
Immune Checkpoint Inhibitor
Locally Advanced Gastric Carcinoma

Interventions

DRUG: FLOT combined with toripalimab

Sponsor

Henan Cancer Hospital